fabio marra

Dr. fabio marra

IBSA Farmaceutici (Italy), Lodi, Italy
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2020 in Molecules
Verified
Journal Article
Open access
PDF file
ICIrma Elisa Cupone
Irma Elisa Cupone
EDEleonora Dellera
Eleonora Dellera
FMfabio marra
fabio marra
AGAndrea Maria Giori
Andrea Maria Giori
Vitamin D plays a crucial and very well-known role in regulation of calcium homeostasis and bone metabolism and mineralization. However, a huge and more recent body of evidence supports the positive influence of vitamin D on the regulation of immune response, ranging from protection against respiratory tract infections to prevention and management of asthma. Nevertheless, vitamin D deficiency is a very common condition and there is an increasing need for suitable products for proper supplementation, allowing good compliance also in specific populations. Orally disintegrating tablets (ODT) were first developed to overcome the difficulty experienced by pediatric and geriatric patients of swallowing traditional oral dosage forms and, recently, orodispersible films (ODF) are gaining popularity as novel dosage form for assuming active pharmaceutical ingredients, vitamins, and ingredients for food supplements. This study describes a 2000 IU Vitamin D3 ODF for daily intake, consisting of hydrophilic polymers and suitable excipients, manufactured by film-casting process. Elongation-at-break (E%), Young’s modulus (Y), and tensile strength (TS) were investigated using a dynamometer. Chemical stability was evaluated assaying the vitamin D3 in the films stored at different environmental conditions. In addition, in vitro disintegration and dissolution studies were performed. Correlation existed between the mechanical properties of the film and the residual water, acting as plasticizer. The stability study showed that vitamin D3 assay was ≥90% also after 3 months at 40 °C. The film disintegrated in less than 1 min and the vitamin D3 released was ≥75% after 15 min. An ODF with suitable properties can be manufactured and used as innovative dosage form for vitamin D3 food supplements.

22 September 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ICIrma Elisa Cupone
Irma Elisa Cupone
Andrea SansoneAndrea Sansone
Andrea Sansone
FMfabio marra
fabio marra
AGAndrea Maria Giori
Andrea Maria Giori
Emmanuele A. JanniniEmmanuele A. Jannini
Emmanuele A. Jannini
Orodispersible film (ODF) is a new dosage form that disperses rapidly in the mouth without water or swallowing. The main ingredient of an ODF is a polymer that can be both of natural or synthetic origin. Maltodextrin is a natural polymer, mainly used in pharmaceutical and nutraceutical fields. This review aims to examine the literature regarding ODFs based on maltodextrin as the platform for developing new products for therapeutical application. ODFs based on maltodextrin contain plasticizers that enhance their flexibility and reduce their brittleness. Surfactants; fillers, such as homopolymer and copolymer of vinylacetate; flavour and sweetener were introduced to improve ODF characteristics. Both water-soluble and insoluble APIs were introduced up to 100 mg per dosage unit. The solvent casting method and hot-melt extrusion are the most useful techniques for preparing ODFs. In particular, the solvent casting method allows manufacturing processes to be developed from a lab scale to an industrial scale. ODFs based on maltodextrin are characterized in terms of mechanical properties, dissolution rate, taste and stability. ODFs made of maltodextrin, developed by IBSA, were tested in vivo to evaluate their bioequivalence and efficacy and were demonstrated to be a valid alternative to the marketed oral dosage forms.

23 May 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ICIrma Elisa Cupone
Irma Elisa Cupone
GRGiuliana Roselli
Giuliana Roselli
FMfabio marra
fabio marra
MRMarika Riva
Marika Riva
ASAngeletti Silvia
Angeletti Silvia
AGAndrea Maria Giori
Andrea Maria Giori
Orodispersible film (ODF) is an innovative dosage form used to administer drugs and nutrients, designed to disintegrate or dissolve in the oral cavity without needing water. One of the advantages of ODF is that it is suitable for administration in older people and children who have difficulty swallowing because of psychological or physiological deficiencies. This article describes the development of an ODF based on maltodextrin, which is easy to administer, has a pleasant taste, and is suitable for iron supplementation. An ODF containing 30 mg of iron as pyrophosphate and 400 µg of folic acid (iron ODF) was developed and manufactured on an industrial scale. The kinetic profile for serum iron and folic acid upon consumption of ODF compared with a Sucrosomial® iron capsule (known for its high bioavailability) was evaluated in a crossover clinical trial. The study was conducted in nine healthy women, and the serum iron profile (AUC0–8, Tmax, and Cmax) of both formulations was defined. Results showed that the rate and extent of elemental iron absorption with iron ODF was comparable to that obtained using the Sucrosomial® iron capsule. These data represent the first evidence of iron and folic acid absorption concerning the newly developed ODF. Iron ODF was proven to be a suitable product for oral iron supplementation.

26 September 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Valeria FrangioneValeria Frangione
Valeria Frangione
CSCristina Sensi
Cristina Sensi
MRMilko Radicioni
Milko Radicioni
FMfabio marra
fabio marra
AGAndrea Maria Giori
Andrea Maria Giori
Introduction: Lorazepam is a widely prescribed benzodiazepine available in multiple pharmaceutical formulations. A novel lorazepam orodispersible film (ODF) has been developed as an alternative dosage form designed to address administration challenges and enhance treatment adherence. Its pharmacokinetic profile, including the rate and extent of absorption, and its tolerability were evaluated in comparison with commercially available oral formulations in two bioequivalence studies. Methods: Two single-center, single-dose, open-label, randomized studies were conducted in healthy adults under fasting conditions. Study A was a three-way crossover pilot study comparing lorazepam 2.5 mg ODF (test, T) with film-coated tablets (Tavor®, reference 1, R1) and orodispersible tablets (Tavor® ORO, reference 2, R2). Study B was a two-way crossover pivotal study comparing T with R1. Treatments were separated by washout periods of ≥7 days. Pharmacokinetic parameters and point estimates (PEs), expressed as the ratios of least-squares geometric means (T/R1 and T/R2), were assessed. Results: In both studies, lorazepam pharmacokinetic profile was comparable across formulations, with similar Cmax and area under the curve (AUC) values. Peak concentrations were reached within 1–1.5 h for all treatments, and the elimination half-life was approximately 15–16 h. The 90% CIs for Cmax, AUC0–t, and AUC0–∞ for T versus R1 and R2 were within the 80–125% bioequivalence range. All treatments were well tolerated, with somnolence being the most frequent adverse event. Conclusions: Lorazepam 2.5 mg ODF demonstrated bioequivalence to both film-coated and orodispersible tablet formulations, with a comparable tolerability profile, supporting its potential as a convenient alternative formulation for lorazepam.

11 October 2024 in IEEE Open Journal of Engineering in Medicine and Biology
Verified
Journal Article
Open access
EBEleonora Barcali
Eleonora Barcali
LMLorenzo Maggi
Lorenzo Maggi
RPRebecca Panconesi
Rebecca Panconesi
Fabio StaderiniFabio Staderini
Fabio Staderini
Leonardo BocchiLeonardo Bocchi
Leonardo Bocchi
ACAndrea Corvi
Andrea Corvi
Goal: Organ perfusion is a vast subject with several techniques, the most common being Hypothermic Machine Perfusion (HMP) and Normothermic Machine Perfusion (NMP). In this paper, a new machine developed at the Biolab of the University of Florence has been tested to validate its capability to perform a well-controlled Oxygenated Rewarming (COR) phase and maintain stability during the NMP phase. Methods: The tests (n = 5) were conducted on fresh porcine livers and evaluated according to liver perfusion standards. The developed machine is based on a previous version, with an integrated control and sensor system and a complete mechanical and electronic redesign. Results: The results demonstrate the excellent usability of the machine and its ability to effectively maintain the organs in good condition. The new system performed well, and the measures made on the livers were satisfactory for good preservation of the organ. Conclusion: This study showed the effectiveness of the developed machine. Future development of the system will include a more sophisticated control system to ensure the correct parameters for perfusion.